White House Backs Bayer's Bid for Supreme Court Review in Roundup Case

Dow Jones
2025/12/02
 

By Billy Gray

 

Bayer said it welcomed the U.S. Solicitor General's support for a Supreme Court review of a case that could curtail longrunning litigation regarding its Roundup pesticide.

The German life-sciences company said the government's support would be significant as the Court weighs its petition, arguing that federal pesticide law preempts state-level failure-to-warn claims. This could limit tens of thousands of lawsuits alleging that the company's Roundup weed-killer causes cancer.

Solicitor General D. John Sauer in a brief said that "[the Environmental Protection Agency] has repeatedly determined that glyphosate is not likely to be carcinogenic in humans, and the agency has repeatedly approved Roundup labels that did not contain cancer warnings."

Bayer previously stated that it aims to significantly contain Roundup litigation by the end of 2026.

 

Write to Billy Gray at william.gray@wsj.com

 

(END) Dow Jones Newswires

December 02, 2025 02:27 ET (07:27 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10